Leflunomide-Associated Pancytopenia With or Without Methotrexate

Abstract

The risk of pancytopenia during leflunomide therapy appears to be increased when the drug is combined with methotrexate and in older patients. Onset may be delayed, and ongoing monitoring of blood counts is essential.